3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Breast
1
Conditions
Breast Neoplasms
294
Triple Negative Breast Neoplasms
50
Inflammatory Breast Neoplasms
19
Breast Neoplasms, Male
18
Neoplasm Metastasis
11
Neoplasms
10
Cardiotoxicity
8
Ovarian Neoplasms
5
Sarcoma
4
Lymphoma, Non-Hodgkin
4
Carcinoma, Ductal, Breast
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lung Neoplasms
3
Invasive Breast Cancer
3
Colorectal Neoplasms
3
Breast Diseases
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neutropenia
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Interventions
Patient Reported Outcome Measures
1
Paclitaxel
1
Laser Therapy
1
Electrosurgery
1
Drug Therapy
1
Doxorubicin
1
Diathermy
1
Cyclophosphamide
1
Carboplatin
1
AC protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hyperthermia
×
Doxorubicin
×
Breast
×
Clear all
NCT01204801
2015-09-24
Medifocus301
Medifocus, Inc.
Phase 3
Unknown
238 enrolled